Changeflow GovPing Healthcare & Life Sciences CRISPR Cpf1 for Acidithiobacillus Ferrooxidans ...
Priority review Rule Added Final

CRISPR Cpf1 for Acidithiobacillus Ferrooxidans Genes

Favicon for changeflow.com USPTO Patent Applications - Biotech (C12N)
Published
Detected
Email

Summary

Columbia University (The Trustees of Columbia University in the City of New York) has filed a published patent application (US20260109942A1) with the USPTO covering methods and genomic editing systems for Acidithiobacillus ferrooxidans using Cpf1 (Cas12a). The application was filed on October 31, 2025 and published on April 23, 2026. Inventors include Scott Banta, Heejung Jung, and Yuta Inaba.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Applications - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 227 changes logged to date.

What changed

The published patent application discloses methods and genomic editing systems for Acidithiobacillus ferrooxidans leveraging Cpf1 (Cas12a) endonuclease technology. The application covers CRISPR-based gene knockdown approaches specific to this chemolithoautotrophic bacterium.

Biotechnology companies and research institutions working on extremophile genome engineering, bioleaching applications, or CRISPR-Cpf1 systems for industrial microorganisms should review this filing for potential freedom-to-operate implications. The breadth of the claims regarding Cpf1 use in A. ferrooxidans may affect similar research programs or commercial applications in biomining and environmental biotechnology.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

CRISPR KNOCKDOWN OT ACIDITHIOBACILLUS FERROOXIDANS GENES

Application US20260109942A1 Kind: A1 Apr 23, 2026

Assignee

The Trustees of Columbia University in the City of New York

Inventors

SCOTT BANTA, HEEJUNG JUNG, YUTA INABA

Abstract

Methods and genomic editing systems for Acidithiobacillus ferrooxidans are described herein involving use of Cpf1 (Cas12a).

CPC Classifications

C12N 1/20 C12N 9/226 C12N 15/113 C12N 15/74 C12N 2310/20 C12N 2310/531 C12R 2001/01

Filing Date

2025-10-31

Application No.

19376033

View original document →

Get daily alerts for USPTO Patent Applications - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 23rd, 2026
Instrument
Rule
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Manufacturers Healthcare providers
Industry sector
3254.1 Biotechnology
Activity scope
Patent filing Genomic editing systems Biotechnology R&D
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare Medical Devices

Get alerts for this source

We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!